{
    "organizations": [],
    "uuid": "23e6732935e7db7ededefa09c3c56a8144215389",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-daiichi-sankyo-initiates-phase-1-s/brief-daiichi-sankyo-initiates-phase-1-study-of-ds-1062-in-patients-with-advanced-non-small-cell-lung-cancer-idUSFWN1QC0V4",
    "ord_in_thread": 0,
    "title": "BRIEF-Daiichi Sankyo Initiates Phase 1 Study Of DS-1062 In Patients With Advanced Non-Small Cell Lung Cancer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 22 (Reuters) - Daiichi Sankyo Co Ltd:\n* DAIICHI SANKYO INITIATES PHASE 1 STUDY OF DS-1062 IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-22T21:13:00.000+02:00",
    "crawled": "2018-02-23T16:13:58.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "daiichi",
        "sankyo",
        "co",
        "ltd",
        "daiichi",
        "sankyo",
        "initiate",
        "phase",
        "study",
        "patient",
        "advanced",
        "cell",
        "lung",
        "cancer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}